World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
43948
World Ranking
7298
National Ranking
3822

Overview

Guido Tricot is affiliated with the University of Iowa in the United States, with a research focus primarily situated within the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work extensively covers subfields such as Hematology, Molecular Biology, Oncology, Immunology, and Genetics.

The main topics of Guido Tricot's research address multiple aspects of cancer biology and treatment. These include:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Cancer Treatment and Pharmacology
  • Peptidase Inhibition and Analysis
  • CAR-T cell therapy research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Biosimilars and Bioanalytical Methods

Their recent publications demonstrate ongoing contributions to the study of hematologic malignancies and targeted therapies. Notable papers include:

  • "Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma" (2022), published in JAMA Network Open
  • "TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies" (2021), published in Journal of Clinical Investigation
  • "Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth" (2024), published in Nature Communications
  • "Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma" (2021), published in Blood Advances
  • "Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a" (2020), published in Molecular Cancer Research

Frequent publication venues include:

  • Blood
  • Cancers
  • Journal of Clinical Investigation
  • Blood Advances
  • Journal of Clinical Oncology

Guido Tricot often collaborates with several researchers in their field. Regular co-authors include:

  • Frits van Rhee
  • Maurizio Zangari
  • Carolina Schinke
  • Sharmilan Thanendrarajan
  • John D. Shaughnessy

Best Publications

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    John D. Shaughnessy;Fenghuang Zhan;Bart E. Burington;Yongsheng Huang

  • Thalidomide and hematopoietic-cell transplantation for multiple myeloma

    Bart Barlogie;Guido Tricot;Elias Anaissie;John Shaughnessy

  • Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

    Fenghuang Zhan;Johanna S. Hardin;Bob Kordsmeier;Klaus Bumm

  • Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

    Bart Barlogie;Sundar Jagannath;David H. Vesole;Sally Naucke

  • Graft-versus-myeloma effect: proof of principle

    Guido Tricot;David H. Vesole;Sundar Jagannath;Jennifer Hilton

  • Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

    B. Barlogie;S. Jagannath;K.R. Desikan;S. Mattox

  • Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.

    Bart Barlogie;Raman Desikan;Raman Desikan;Paul Eddlemon;Paul Eddlemon;Trey Spencer;Trey Spencer

  • Treatment of multiple myeloma

    Bart Barlogie;John D Shaughnessy;Guido Tricot;Joth Jacobson

  • Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients

    Guido Tricot;Sundar Jagannath;David Vesole;Jean Nelson

  • Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

    Ichiro Hanamura;James P. Stewart;James P. Stewart;Yongsheng Huang;Yongsheng Huang;Fenghuang Zhan;Fenghuang Zhan

  • Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

    Maurizio Zangari;Elias Anaissie;Bart Barlogie;Ashraf Badros

  • Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

    Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

  • Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities

    Guido Tricot;Bart Barlogie;Sundar Jagannath;Dwayne Bracy

  • Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.

    Pei Lin;Rebecca Owens;Guido Tricot;Carla S. Wilson

  • Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications

    Ronald Walker;Bart Barlogie;Jeffrey Haessler;Guido Tricot

  • Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

    Fenghuang Zhan;Bart Barlogie;Varant Arzoumanian;Yongsheng Huang

  • Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.

    Raman Desikan;Bart Barlogie;Bart Barlogie;Jeffrey Sawyer;Jeffrey Sawyer;Dan Ayers;Dan Ayers

  • Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell Tumors

    Craig R. Nichols;Bruce J. Roth;Nyla Heerema;John Griep

Frequent Co-Authors

Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Maurizio Zangari
Maurizio Zangari University of Arkansas for Medical Sciences
Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
Elias Anaissie
Elias Anaissie University of Cincinnati
John D. Shaughnessy
John D. Shaughnessy University of Arkansas for Medical Sciences
Sundar Jagannath
Sundar Jagannath Icahn School of Medicine at Mount Sinai
David H. Vesole
David H. Vesole Rutgers, The State University of New Jersey
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences
Nikhil C. Munshi
Nikhil C. Munshi Harvard University
John N. Crowley
John N. Crowley Max Planck Society

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to a wide range of rewarding roles beyond becoming a physician. For those interested in the business and leadership side of healthcare, earning a health administration degree online can provide critical management skills and prepare you for administrative roles in hospitals, clinics, or public health organizations.

If you're looking to further specialize, the cheapest mha programs offer an affordable path to advanced positions in healthcare management and policy. For nurses seeking to advance their practice, the cheapest dnp programs allow you to reach the highest levels of clinical expertise without interrupting your career.

Pharmacists can also study at the doctoral level with flexible online pharmd programs, preparing for clinical, academic, or leadership opportunities in pharmacy. Whether your passion is patient care, administration, or research, these online degree options offer accessible and affordable routes to diverse healthcare careers in the USA.

Best Scientists Citing Guido Tricot

Trending Scientists

Recently Published Articles